Delayed breast cancer relapse with pleural metastasis and malignant pleural effusion after long periods of disease-free survival

被引:8
|
作者
Rawindraraj, Antony Divananth [1 ]
Zhou, Christine Yang [1 ]
Pathak, Vikas [1 ,2 ]
机构
[1] Campbell Univ, Sch Osteopath Med, Dept Internal Med, Lillington, NC USA
[2] WakeMed Hlth & Hosp, Dept Pulm & Crit Care Med, Raleigh, NC USA
来源
RESPIROLOGY CASE REPORTS | 2018年 / 6卷 / 09期
关键词
Breast cancer relapse; breast cancer metastasis; malignant pleural effusion; pleural effusion;
D O I
10.1002/rcr2.375
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Breast cancer relapse remains a common cause of morbidity and mortality in patients who undergo initial treatment with surgery and with or without concurrent chemotherapy or radiation. Relapse rates remain high within the first decade after initial treatment, after which the risk of relapse decreases. While common within the first year of breast cancer diagnosis, pleural metastasis with malignant pleural effusion (MPE) after 10-12 years of a disease-free period is rare. Here, we present two uncommon cases of delayed breast cancer relapses with pleural metastasis, which caused MPEs.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Breast and Lung Effusion Survival Score Models Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis
    Molina, Sofia
    Martinez-Zayas, Gabriela
    Sainz, Paula, V
    Leung, Cheuk H.
    Li, Liang
    Grosu, Horiana B.
    Adachi, Roberto
    Ost, David E.
    CHEST, 2021, 160 (03) : 1075 - 1094
  • [2] Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer
    Xie, She-Ling
    Yang, Meng-Hang
    Chen, Kun
    Huang, Hai
    Zhao, Xue-Wei
    Zang, Yuan-Sheng
    Li, Bing
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (03) : 1325 - 1333
  • [3] EFFICACY OF ARSENIC TRIOXIDE IN THE TREATMENT OF MALIGNANT PLEURAL EFFUSION CAUSED BY PLEURAL METASTASIS OF LUNG CANCER
    Zang, Yuan-Sheng
    Xie, She-Ling
    Zhao, Xue-Wei
    Li, Bing
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1035 - S1036
  • [4] Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer
    She-Ling Xie
    Meng-Hang Yang
    Kun Chen
    Hai Huang
    Xue-Wei Zhao
    Yuan-Sheng Zang
    Bing Li
    Cell Biochemistry and Biophysics, 2015, 71 : 1325 - 1333
  • [5] Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion
    dos Santos, Giovana Tavares
    Prolla, Joao Carlos
    Camillo, Natalia Dressler
    Zavalhia, Lisiane Silveira
    Ranzi, Alana Durayski
    Bica, Claudia Giuliano
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2012, 38 (04) : 487 - 493
  • [6] Lung cancer with malignant pleural effusion: Clinical and survival characteristics
    Mullon, J
    Swanson, K
    Jett, J
    Sahn, S
    LUNG CANCER, 2005, 49 : S259 - S259
  • [7] An unusual case of breast cancer relapse after 30 years of disease-free survival
    Dal Lago, D
    Villa, G
    Miglioli, R
    Annoni, G
    Vergani, C
    AGE AND AGEING, 1998, 27 (05) : 649 - +
  • [8] Treatment strategies in malignant pleural effusion because of breast cancer
    Wolters, U
    Türler, A
    ZENTRALBLATT FUR CHIRURGIE, 1998, 123 : 128 - 129
  • [9] Prognostic Factors in Patients with Breast Cancer and Malignant Pleural Effusion
    van Galen, Karin P. M.
    Visser, Hein P. J.
    van der Ploeg, Tjeerd
    Smorenburg, Carolien H.
    BREAST JOURNAL, 2010, 16 (06): : 675 - 677
  • [10] Intrathoracic paclitaxel chemotherapy for malignant pleural effusion in breast cancer
    Yeu, K. J.
    Park, J.
    Choi, J. E.
    Kang, S. H.
    Lee, S. J.
    CANCER RESEARCH, 2016, 76